ProPhase Labs GAAP EPS of -$0.11, revenue of $1.2M

Published 2 months ago • Aug 13, 2025 at 2:06 PM • Positive

Auto

* ProPhase Labs press release [https://seekingalpha.com/pr/20199349-prophase-labs-announces-financial-results-for-the-three-and-six-months-ended-june-30-2025] (NASDAQ:PRPH [https://seekingalpha.com/symbol/PRPH]): Q2 GAAP EPS of -$0.11.
* Revenue of $1.2M.
*

MORE ON PROPHASE LABS

* ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript [https://seekingalpha.com/article/4788650-prophase-labs-inc-prph-q1-2025-earnings-call-transcript]
* ProPhase Labs receives extension from Nasdaq to regain compliance [https://seekingalpha.com/news/4462728-prophase-labs-receives-extension-from-nasdaq-to-regain-compliance]
* Seeking Alpha’s Quant Rating on ProPhase Labs [https://seekingalpha.com/symbol/PRPH/ratings/quant-ratings]
* Historical earnings data for ProPhase Labs [https://seekingalpha.com/symbol/PRPH/earnings]
* Financial information for ProPhase Labs [https://seekingalpha.com/symbol/PRPH/income-statement]

More News

Leishen Energy(LSE) Makes a Strong Debut at ADIPEC Abu Dhabi, Embarking on a New Chapter of Strategic Expansion in the Middle East and International Markets

20 minutes ago Positive

Startups from Australia, India and UAE crowned winners in L'Oréal Groupe's biggest Beauty Tech competition across South Asia Pacific, Middle East and North Africa

40 minutes ago Positive

Kirin: Development of a Fermented Ingredient Derived from Coffee Cherries to Enhance Body and Aroma Contributing to the Sustainability of Coffee Farms, Reduction of Environmental Impact, and Addressing Alcohol-related Social Issues

44 minutes ago Positive

ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Cytokinetics, Inc. Investors to Secure Counsel Before Important November 17 Deadline in Securities Class Action – CYTK